Read More Pharma Industry News Vertex Pharmaceuticals bags UK approval for ALYFTREK, a next-generation cystic fibrosis treatment The United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) has granted approval for ALYFTREK (deutivacaftor/tezacaftor/vanzacaftor), a next-generation… byPallavi MadhirajuMarch 7, 2025